Form 4 for CELU Celularity Inc

Accepted 2022-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0000899243-22-036452 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-11-18	2021-11-16	CELU	Glover Bradley	See Remarks	F - Tax	$1.89	-3,734	54.1K	-6%	-$7,057
	2022-11-18	2021-11-16	CELU	Glover Bradley	See Remarks	A - Grant	$0.00	+25.0K	57.8K	+76%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-11-16	F	D	3,734	$1.89	54,076	D	—	—	(F3) Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under 2021 Plan and does not represent a sale. (F4) Includes 45,310 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.
2	Common	Class A Common Stock	2021-11-16	A	A	25,000	$0.00	57,810	D	—	—	(F1) These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date. (F2) Represents 57,810 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.